Scientists are raising questions about Moderna’s COVID-19 vaccine trial and results, as the company has yet to reveal data that supports how its drug is successfully producing antibodies in human trials. Yahoo Finance’s Anjalee Khemlani joins the On the Move panel to discuss. …read more
Source:: Yahoo Finance
